trial

Suicide Prevention Intervention for Schizophrenia-Spectrum Disorders

NCTId NCT04221269
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 30 (actual)
Sponsored by Butler Hospital
Primary completion 2023-06-01
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
30 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Single
Start
2020-12-01
Primary completion
2023-06-01
Eligibility
ALL · 18 Years

Interventions & indications

Drugs
Coping Long-term with Active Suicide Program for Schizophrenia

Sponsors

Butler HospitalLead Sponsor
American Foundation for Suicide PreventionCollaborator

Investigators

1
Brandon Gaudiano, PhDPrincipal Investigator

Sites

1 total
Providence, United States

Facts & assertions

4 sourced
Enrollment
30
Phase
NA
Primary Completion Date
2023-06-01
Status
COMPLETED
relationships
The graph out of here
drug
Coping Long-term with Active Suicide Program for Schizophrenia
drug
lead_sponsor
Butler Hospital
company
collaborator
American Foundation for Suicide Prevention
company
indication
Psychotic Disorders
indication
Schizophrenia
indication
Schizophrenia
indication
investigator
Brandon Gaudiano, PhD
person